Opportunity for Pharmaceutical Intervention in Lung Cancer: Selective Inhibition of JAK1/2 to Eliminate EMT-Derived Mesenchymal Cells

Michael M. C. Lai(University of Southern California)
Unknown
November 1, 1997
Cited by 0


Related Papers